Could COVID-19 studies already be providing clues about what went wrong with the long haulers and people with post-infectious chronic fatigue syndrome (ME/CFS), fibromyalgia and other diseases? Two articles in the New York Times – a feature length one,...
Media Barrage A veritable avalanche of stories – the C19Recovery Awareness website provides a link to approximately 50 articles since June 1st – have highlighted the problems that many people have had recovering from the coronavirus. With eight stories...
Sustained Stimulation of β2- and β3-adrenergic Receptors Leads to Persistent Functional Pain and Neuroinflammation. Xin Zhang, MD, PhD, Jane E. Hartung PhD, […], and Andrea G. Nackley PhD, PhD. Brain Behav Immun 2018 Oct;73:520-532. doi:...
EpicGenetics – a biotech firm in Los Angeles – is attempting an FM trifecta: produce a blood and genomic test and provide a treatment. EpicGenetics is trying to make a big splash in fibromyalgia. A Los Angeles biotech firm, they focused on producing...
Cytokines have been like a mirage in the desert for ME/CFS. These powerful immune factors seem like they must play a major role in this disease, but as soon as researchers have closed in on them, they’ve always seemed to slip away. A recent major review from the...
A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision. The study possibly identified...
